Iscia Lopes-Cendes, MD, PhD, University of Campinas, Campinas, Brazil, talks on the progression of research on targeting epilepsy treatments to the molecular diagnosis to develop individualized drugs for specific genetic defects. Prof. Lopes-Cendes discusses the possibility of gene therapy and new techniques being researched. This interview took place during the 34th International Epilepsy Congress, 2021.

свернуть